A study on safety and efficacy comparing 150cm One Anastomosis Gastric Bypass with 150cm BP limb Roux-en-Y Gastric Bypass (Roux-en-WHY?): An open label, multicentre non-inferiority randomized controlled trial
- Conditions
- obesitasObestityoverweight1001842410017998
- Registration Number
- NL-OMON54369
- Lead Sponsor
- Flevoziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 298
Inclusion criteria are BMI >40kg/m2, or BMI >35kg/m2 with at least one of the
following comorbidities: type 2 diabetes, hypertension, dyslipidaemia,
obstructive sleep apnoea, or osteoarthritis of the hip or knee; age 18-65
years; positive evaluation by a Bariatric multidisciplinary team (BMDT,
consisting of psychologists, dietitians, internists and bariatric surgeons);
and written informed consent
Exclusion criteria will be presence of Helicobacter pylori resistant to
eradication therapy, the presence of chronic diarrhoea, or previous bariatric
or extensive abdominal surgery.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>% excess BMI loss at 2 years</p><br>
- Secondary Outcome Measures
Name Time Method